Sino Biological Inc
SZSE:301047
Sino Biological Inc
SZSE:301047
Price:
63.5 CNY
-1.09%
Updated:
Jun 10, 2024
Sino Biological Inc
Cash from Investing Activities
|
Sino Biological Inc
Cash from Investing Activities Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sino Biological Inc
SZSE:301047
|
Cash from Investing Activities
-¥1.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-97%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Cash from Investing Activities
¥117.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Investing Activities
-¥998.7m
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Investing Activities
-¥942.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-14%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Investing Activities
-¥943.7m
|
CAGR 3-Years
-233%
|
CAGR 5-Years
-143%
|
CAGR 10-Years
N/A
|
See Also
What is Sino Biological Inc's Cash from Investing Activities?
Cash from Investing Activities
-1.2B
CNY
-1.2B
CNY
Based on the financial report for Dec 31, 2023, Sino Biological Inc's Cash from Investing Activities amounts to -1.2B CNY.
What is Sino Biological Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-97%
-97%
Over the last year, the Cash from Investing Activities growth was -1 752%. The average annual Cash from Investing Activities growth rates for Sino Biological Inc have been -5% over the past three years , -97% over the past five years .
You don't have any saved screeners yet
